Recently, animal studies demonstrated that blockade of the CTLA-4 or PD-1/PD-L1 pathway improved survival in several clinically relevant models of sepsis, which highlighted the significant degree of coinhibitory molecules in sepsis-induced immune dysfunction [7]. This evidence concerns the gene CD274 and Sepsis.